8ème Workshop ELI – Amsterdam 2022
2022 | Europe | Workshop
21 Apr, 2022

“T-cell lymphoma in Europe”.

The last ELI Workshop took place on 29 and 30 September 2022 in Amsterdam on the theme of T-cell Lymphoma.

Scientific Committee
François Lemonnier, France
Marcin Szymanski, Poland
Tarec El Galaly, Denmark
Ivan Dlouhy, Portugal
Yana Stepanishyna, Ukraine
Tetiana Skrypets, Italy 

Joost Vermaat, NL
Thomas Weber, Germany
Raphael Koch, Germany
Pavel Klener, Czech Rep
Andrea Janikova, Czech Rep
Alejandro Martín, Spain

Topics
Epidemiology and rare entities
Diagnosis and classification
Controversies in frontline treatment
Immunotherapy and novel approaches

The detailed programme is available here.

Free but compulsory registration with Claire Morin.

our last news
on twitter

ELI Follow

The European Lymphoma Institute

Avatar
Retweet on Twitter ELI Retweeted
Avatar

André Marc

@marcandre64 ·
17 Nov 2023

Happy to see our paper about long term results of the H10 trial for early stage Hodgkin lymphoma. Fantastic collaboration for LYSA with FIL and EORTC.

Reply on Twitter 1725583785398280502 Retweet on Twitter 1725583785398280502 5 Like on Twitter 1725583785398280502 23 Twitter 1725583785398280502

Similar topics…

Workshop 2026 / programme

Aug 10, 2026

🌍 ELI Workshop 2026 – Bellinzona, Switzerland 📅 September 18–19, 2026 🧬 Focus: Marginal Zone Lymphoma Final programme available here Information and registration by Claire Morin

Lymphoma Hub Symposium

Jun 16, 2026

Optimizing treatment for chronic lymphocytic leukemia with BTK inhibitors Monday, June 22, 2026 20:00 BST (21:00 CEST) Join us for this informative session chaired by Gilles Salles and featuring distinguished experts Susan O'Brien, Farrukh Awan, and Francesc Bosch....

2026 Call – Short Study Stays in Europe

Jun 2, 2026

ELI is pleased to launch its 2026 call for short study stays in European lymphoma centers. 🔎 Key information: Objective: Promote education, training and collaboration in lymphoma care across Europe Who can apply: Early-career clinical physicians involved in lymphoma...

See all news